Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Why sepsis trials fail.

Bone RC.

JAMA. 1996 Aug 21;276(7):565-6. Review. No abstract available.

PMID:
8709407
2.

[Infection and inflammation in sepsis].

Surbatović M, Filipović N, Slavković Z, Radaković S.

Vojnosanit Pregl. 2006 Feb;63(2):163-8. Review. Serbian. No abstract available.

PMID:
16502992
3.

HMGB1, a potent proinflammatory cytokine in sepsis.

Huang W, Tang Y, Li L.

Cytokine. 2010 Aug;51(2):119-26. doi: 10.1016/j.cyto.2010.02.021. Epub 2010 Mar 26. Review.

PMID:
20347329
4.

Coagulation inhibition for sepsis.

Key NS, Ely EW.

Curr Opin Hematol. 2002 Sep;9(5):416-21. Review.

PMID:
12172460
5.

Should we target blood pressure in sepsis?

Takala J.

Crit Care Med. 2010 Oct;38(10 Suppl):S613-9. doi: 10.1097/CCM.0b013e3181f2430c. Review.

PMID:
21164405
6.

Sepsis as a model of SIRS.

Bhatia M, He M, Zhang H, Moochhala S.

Front Biosci (Landmark Ed). 2009 Jan 1;14:4703-11. Review.

PMID:
19273383
7.

Definitions and pathophysiology of sepsis.

Sagy M, Al-Qaqaa Y, Kim P.

Curr Probl Pediatr Adolesc Health Care. 2013 Nov-Dec;43(10):260-3. doi: 10.1016/j.cppeds.2013.10.001. Review.

PMID:
24295606
8.

Activated protein C: controversy and hope in the treatment of sepsis.

Baillie JK.

Curr Opin Investig Drugs. 2007 Nov;8(11):933-8. Review.

PMID:
17979027
9.

Targeting high mobility group box 1 as a late-acting mediator of inflammation.

Czura CJ, Tracey KJ.

Crit Care Med. 2003 Jan;31(1 Suppl):S46-50. Review.

PMID:
12544976
10.

Calcium: a regulator of the inflammatory response in endotoxemia and sepsis.

Hotchkiss RS, Karl IE.

New Horiz. 1996 Feb;4(1):58-71. Review.

PMID:
8689276
11.

Update on sepsis: pathophysiology and treatment.

Vincent JL.

Acta Clin Belg. 2000 Mar-Apr;55(2):79-87. Review.

PMID:
10881372
12.

Clinical trial design and outcomes in patients with severe sepsis.

Opal SM.

Shock. 2003 Oct;20(4):295-302. Review.

PMID:
14501941
13.

Lessons for the future: a review of sepsis past and present.

Kaplan BI, Tipirneni P.

IDrugs. 2007 Apr;10(4):264-9. Review.

PMID:
17390250
14.

Spectrum of sepsis, mediators, source control and management of bundles.

Gullo A, Foti A, Murabito P, Li Volti G, Astuto M, Stissi C, Rubulotta F, Sanfilippo F, Santonocito C, Sganga G, Ristagno G.

Front Biosci (Elite Ed). 2010 Jun 1;2:906-11. Review.

PMID:
20515762
15.

Antimicrobial effects of antiinflammatory drugs, antiinflammatory effects of antimicrobial drugs.

Bannwarth B.

Rev Rhum Engl Ed. 1999 Jan 30;66(1 Suppl):73S-76S. Review. No abstract available.

PMID:
10063531
16.

Animal models of sepsis: setting the stage.

Buras JA, Holzmann B, Sitkovsky M.

Nat Rev Drug Discov. 2005 Oct;4(10):854-65. Review.

PMID:
16224456
17.

[Severe sepsis--new therapeutic options].

Walmrath D, Grimminger F, Seeger W.

Internist (Berl). 2001 Dec;42(12):1619-20, 1623-30. Review. German. No abstract available.

PMID:
11793601
18.

Role of soluble mediators in sepsis and renal failure.

Camussi G, Ronco C, Montrucchio G, Piccoli G.

Kidney Int Suppl. 1998 May;66:S38-42. Review. No abstract available.

PMID:
9573571
19.

Disseminated intravascular coagulation in sepsis.

Zeerleder S, Hack CE, Wuillemin WA.

Chest. 2005 Oct;128(4):2864-75. Review.

PMID:
16236964
20.

Alterations in calcium signaling and cellular responses in septic injury.

Sayeed MM.

New Horiz. 1996 Feb;4(1):72-86. Review.

PMID:
8689277

Supplemental Content

Support Center